Filing Details
- Accession Number:
- 0001171843-17-007216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-21 17:00:24
- Reporting Period:
- 2017-11-20
- Accepted Time:
- 2017-11-21 17:00:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 722830 | Immunomedics Inc | IMMU | In Vitro & In Vivo Diagnostic Substances (2835) | 611009366 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1283061 | A Brian Markison | C/O Immunomedics, Inc. 300 The American Road Morris Plains NJ 07950 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-11-20 | 15,000 | $3.16 | 99,178 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-11-20 | 8,390 | $11.89 | 90,788 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.01 Per Share | Stock Options (right to buy) | Disposition | 2017-11-20 | 15,000 | $0.00 | 15,000 | $3.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-12-01 | 2017-12-01 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average price. The prices actually received by the reporting person in this transaction range from $11.88 to $11.92.
- The reporting person has provided to the issuer, and the issuer will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range reported.
Billionaire Hedge Funds
